This study is
approved consistent with the revised supporting statement and
instruments of (7/13/05) under the following conditions: 1) In
describing the results of the study, as indicated in the supporting
statement, FDA will clearly acknowledge limitations of the study
(e.g., Synovate Panel is a convenience sample and the Knowledge
Networks Panel may not provide a nationally representative
estimates). 2) FDA shall submit the final versions of the
questionnaire and related material after pre-testing for OMB
approval using the change worksheet (83-C). 3) FDA shall submit a
summary of the survey results including the cumulative response
rates and survey response rates upon completion of the study.
Inventory as of this Action
Requested
Previously Approved
07/31/2008
07/31/2008
5,060
0
0
845
0
0
0
0
0
The purpose of this proposed data
collection is to collect information from food allergic consumers
and their caregivers, and from people who do not fit that category,
on their food allergy labeling preferences and the effectiveness of
a variety of food allergy labeling formats and food allergy
labeling statements.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.